REVA Medical
PrivateLast Round
Series B
Aug 9, 2022
Est. Valuation
$345M
Total Funding Raised
$112M
Company Overview
REVA Medical is a medical device company that develops and commercializes bioresorbable polymer technologies for vascular applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
REVA Medical Comparables
Compare REVA Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| R3 Vascular Inc. | 89% | |
| Elixir Medical Corporation | 88% | |
| Abbott Laboratories | 79% | |
REVA Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 9, 2022 | ||||
| Debt | Jan 14, 2020 | ||||
| Debt | Mar 24, 2019 | ||||
| Convertible Debt | Jun 16, 2017 | ||||
| Convertible Debt | Nov 20, 2014 | ||||
IPO | Dec 21, 2010 |
REVA Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Elliott Investment Management L.P. | Debt |
| Domain Associates | Private Placement |
| Pequot Capital Management | Private Placement |
| Boston Scientific Corporation | Private Placement, Series B |
| Taylor Collison Limited | IPO |
| Goldman Sachs International | Debt |
| Brookside Capital Partners | Private Placement |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 9, 2022
$45M round led by Boston Scientific Corporation
- Jan 14, 2020
Secured $4.4M in debt financing from Elliott Investment Management and Goldman Sachs.
REVA Medical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |